A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea

PLoS Neglected Tropical Diseases

Volumn 10, Issue 3, 2016, Pages

  Palich, Romain ^a   Gala, Jean Luc ^b   Petitjean, Frédéric ^a   Shepherd, Susan ^a   Peyrouset, Olivier ^a   Abdoul, Bing M ^a   Kinda, Moumouni ^a   Danel, Christine ^c   Augier, Augustin ^a   Anglaret, Xavier ^c   Malvy, Denis ^c,d   Blackwell, Nicole ^a,e   Séto, Camara M ^a   Lolamou, René ^a   Bérété, Sakoba ^a   Condé, Sekou ^a   Abdoulaye, Soumah ^a   Fara, Roger K ^a   Sadou, Barry T ^a   Moriba, Loua C ^a   Lanciné, Doumbouya ^a   Nantenin, Condé M ^a   Samaké, Nenefing ^a   more..

^a Alliance for International Medical Action ^*

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c INSERM U657   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CEFTRIAXONE; CIPROFLOXACIN; FAVIPIRAVIR; INFUSION FLUID; LOPERAMIDE; ONDANSETRON; PARACETAMOL; AMIDE; ANTIVIRUS AGENT; PYRAZINE DERIVATIVE;

ABDOMINAL PAIN; ARTHRALGIA; ARTICLE; CASE REPORT; CHILD; DIARRHEA; DROWSINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; EBOLA HEMORRHAGIC FEVER; FEVER; GENERALIZED EDEMA; GUINEA; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; HYPOVOLEMIA; LETHARGY; MALE; METABOLIC ACIDOSIS; MYALGIA; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TACHYCARDIA; TACHYPNEA; THRUSH; TONIC CLONIC SEIZURE; VOMITING; COMPLICATION; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; ISOLATION AND PURIFICATION; LIMIT OF DETECTION; PATHOLOGY; VIRUS LOAD;

AMIDES; ANTIVIRAL AGENTS; CHILD; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; LIMIT OF DETECTION; MALE; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84962429847     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004393     Document Type: Article

References (6)

1. WHO Ebola Response TeamEbola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481–95. doi: 10.1056/NEJMoa141110025244186
2. Sissoko D, Laouenan C, Folkesson E, M’Lebing A-B, Beavogui A-H, Baize S, et al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016;13(3):e1001967. doi: 10.1371/journal.pmed.100196726930627
3. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol2004;78:4330–41. 15047846
4. Kourtis AP, Appelgren K, Chevalier MS, McElroy A, Ebola Virus Disease: Focus on Children. Pediatr Infect Dis J. 2015;34(8):893–7. doi: 10.1097/INF.000000000000070725831417
5. WHO Ebola Response TeamAgua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, et al. Ebola virus disease among children in West Africa. N Engl J Med. 2015; 372(13):1274–7.
6. Wolf T, Kann G, Becker S, Stephan C, Brodt H-R, de Leuw P, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2015;385(9976):1428–1435. doi: 10.1016/S0140-6736(14)62384-925534190